CRBP vs. HSBC
CRBP (Corbus Pharmaceuticals Holdings, Inc.) and HSBC (HSBC Holdings plc) are both stocks. CRBP operates in Biotechnology (Healthcare), while HSBC operates in Banks - Diversified (Financial Services). Over the past 10 years, CRBP returned -20.07%/yr vs 19.27%/yr for HSBC. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
CRBP vs. HSBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRBP achieves a 10.20% return, which is significantly lower than HSBC's 39.85% return. Over the past 10 years, CRBP has underperformed HSBC with an annualized return of -20.07%, while HSBC has yielded a comparatively higher 19.27% annualized return.
CRBP
- 1D
- -0.88%
- 1M
- -3.03%
- 6M
- 8.46%
- YTD
- 10.20%
- 1Y
- -3.65%
- 3Y*
- 7.40%
- 5Y*
- -26.25%
- 10Y*
- -20.07%
- ALL TIME*
- -17.86%
HSBC
- 1D
- -0.63%
- 1M
- 9.96%
- 6M
- 25.01%
- YTD
- 39.85%
- 1Y
- 81.91%
- 3Y*
- 46.00%
- 5Y*
- 39.37%
- 10Y*
- 19.27%
- ALL TIME*
- 7.24%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $2.30M | $2.68M | $4.28M | |
| $138.88M | $132.62M | $146.00M |
CRBP vs. HSBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 10.20% | -31.02% | 95.36% | 82.20% | -82.05% | -50.74% | -77.11% | -6.51% | -17.75% | -15.98% |
HSBC HSBC Holdings plc | 39.85% | 67.91% | 34.48% | 39.45% | 7.79% | 20.76% | -31.71% | 1.44% | -16.05% | 36.04% |
Correlation
The correlation between CRBP and HSBC is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.14 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.14 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 11, 2014 | 0.14 |
Fundamentals
CRBP:
$166.19M
HSBC:
$365.74B
CRBP:
-$5.72
HSBC:
$6.41
CRBP:
1.33
HSBC:
2.11
CRBP:
$0.00
HSBC:
$128.37B
CRBP:
-$149.00K
HSBC:
$65.42B
CRBP:
-$61.36M
HSBC:
$34.27B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRBP vs. HSBC — Risk / Return Rank
CRBP
HSBC
CRBP vs. HSBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Corbus Pharmaceuticals Holdings, Inc. (CRBP) and HSBC Holdings plc (HSBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRBP | HSBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.10 | ||
| Sortino ratioReturn per unit of downside risk | -3.35 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.50 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.05 | 5.07 | -5.12 |
| Martin ratioReturn relative to average drawdown | -0.07 | 18.15 | -18.22 |
Loading charts...
Drawdowns
CRBP vs. HSBC - Drawdown Comparison
The maximum CRBP drawdown since its inception was -99.31%, which is greater than HSBC's maximum drawdown of -74.47%. Use the drawdown chart below to compare losses from any high point for CRBP and HSBC.
Loading charts...
Drawdown Indicators
| CRBP | HSBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.31% | -74.47% | -24.84% |
Max Drawdown (1Y)Largest decline over 1 year | -61.88% | -16.28% | -45.60% |
Max Drawdown (3Y)Largest decline over 3 years | -92.01% | -21.83% | -70.18% |
Max Drawdown (5Y)Largest decline over 5 years | -94.87% | -31.80% | -63.07% |
Max Drawdown (10Y)Largest decline over 10 years | -99.31% | -62.26% | -37.05% |
Current DrawdownCurrent decline from peak | -97.11% | -0.63% | -96.48% |
Average DrawdownAverage peak-to-trough decline | -66.40% | -23.98% | -42.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.40% | 4.54% | +40.86% |
Volatility
CRBP vs. HSBC - Volatility Comparison
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a higher volatility of 11.86% compared to HSBC Holdings plc (HSBC) at 7.09%. This indicates that CRBP's price experiences larger fluctuations and is considered to be riskier than HSBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRBP | HSBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.86% | 7.09% | +4.77% |
Volatility (6M)Calculated over the trailing 6-month period | 59.99% | 22.60% | +37.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.24% | 26.99% | +52.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 159.05% | 25.99% | +133.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 129.03% | 25.42% | +103.61% |
Dividends
CRBP vs. HSBC - Dividend Comparison
CRBP has not paid dividends to shareholders, while HSBC's dividend yield for the trailing twelve months is around 3.52%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRBP Corbus Pharmaceuticals Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
HSBC HSBC Holdings plc | 3.52% | 4.19% | 8.29% | 6.54% | 4.33% | 3.65% | 4.05% | 6.52% | 6.20% | 4.94% | 6.35% | 6.33% |
Financials
CRBP vs. HSBC - Financials Comparison
This section allows you to compare key financial metrics between Corbus Pharmaceuticals Holdings, Inc. and HSBC Holdings plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CRBP and HSBC have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRBP has higher volatility (11.86%) compared to HSBC (7.09%). In terms of maximum drawdown, CRBP dropped -99.31% vs HSBC's -74.47%.
HSBC currently has the higher Sharpe Ratio (3.06 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRBP and HSBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer